Back to Search Start Over

Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL).

Authors :
Rogers, Kerry A.
Thompson, Philip A.
Allan, John N.
Coleman, Morton
Sharman, Jeff P.
Cheson, Bruce D.
Izumi, Raquel
Frigault, Melanie M.
Quah, Cheng
Raman, Rakesh K.
Wang, Min Hui
Kipps, Thomas J.
Source :
Clinical Lymphoma, Myeloma & Leukemia; 2019 Supplement 1, Vol. 19, pS282-S283, 2p
Publication Year :
2019

Details

Language :
English
ISSN :
21522650
Volume :
19
Database :
Complementary Index
Journal :
Clinical Lymphoma, Myeloma & Leukemia
Publication Type :
Academic Journal
Accession number :
142669501
Full Text :
https://doi.org/10.1016/j.clml.2019.07.220
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details